Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

NCT00361140

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +16 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma

NCT00523848

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

NCT00416624

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 326 locations

View Trial Details

Completed

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

NCT00256880

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Durham, North Carolina, United States

GSK Investigational Site Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

NCT01171092

Conditions: Autologous Transplant, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

University of Kansas Medical Center, Westwood Campus Westwood, Kansas, United States

View Trial Details

Completed

Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00006021

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Cedars Medical Center Miami, Florida, United States

University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States

Baptist-South Miami Regional Cancer Program Miami, Florida, United States

Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center Miami Beach, Florida, United States

View Trial Details

Completed

Acupuncture for Chemo-Induced Peripheral Neuropathy

NCT00891618

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

NCT00800839

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy

NCT01132833

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions